ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography): Developed in collaboration with the North American Society for Pacing and Electrophysiology

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 912-948

  Crawford, Michael H ^a   Bernstein, Steven J ^a   Deedwania, Prakash C ^a   DiMarco, John P ^a   Ferrick, Kevin J ^a   Garson Jr , Arthur ^a   Green, Lee A ^a   Greene, H Leon ^a   Silka, Michael J ^a   Stone, Peter H ^a   Tracy, Cynthia M ^a   Gibbons, Raymond J ^a   Alpert, Joseph S ^a   Eagle, Kim A ^a   Gardner, Timothy J ^a   Gregoratos, Gabriel ^a   Russell, Richard O ^a   Ryan, Thomas J ^a   Smith Jr , Sidney C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY MONITORING; ARTIFACT REDUCTION; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HUMAN; HUMAN TISSUE; MEDICAL INSTRUMENTATION; PACEMAKER; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0032835987     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00354-X     Document Type: Article

References (304)

1. Knoebel S.B., Crawford M.H., Dunn M.I., et al. Guidelines for ambulatory electrocardiography a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Ambulatory Electrocardiography) . J Am Coll Cardiol. 13:1989;249-258.
2. Cheitlin M.D., Alpert J.S., Armstrong W.F., et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in Collaboration with the American Society of Echocardiography . Circulation. 95:1997;1686-1744.
3. Association for the Advancement of Medical Instrumentation. American national standard: ambulatory electrocardiographs. Arlington, VA: ANSI/AAMI; 1994. EC 38.
4. Bragg-Remschel D.A., Anderson C.M., et al. Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis. Am Heart J. 103:1982;20-31.
5. Shook T.L., Balke C.W., Kotilainen P.W., et al. Comparison of amplitude-modulated (direct) and frequency-modulated ambulatory techniques for recording ischemic electrocardiographic changes. Am J Cardiol. 60:1987;895-900.
6. Nearing B.D., Stone P.H., Verrier R.L. Frequency response characteristics required for detection of T-wave alternans during ambulatory ECG monitoring. Ann Noninvas Electrocardiol. 1:1996;103-112.
7. Phadke K., Mulcahy D., Fox K. Clinical validation of four solid state ambulatory monitoring devices in detecting shift of the ST segment. Int J Cardiol. 33:1991;445-446.
8. Lanza G.A., Lucente M., Rebuzzi A.G., et al. Accuracy in clinical arrhythmia detection of a real-time Holter system (Oxford Medilog 4500). J Electrocardiol. 23:1990;301-306.
9. Kennedy H.L., et al. Limitations of ambulatory ECG real-time analysis for ventricular and supraventricular arrhythmia accuracy detected by clinical evaluation. Am J Noninvas Cardiol. 6:1992;137-146.
10. Lanza G.A., Mascellanti M., Placentino M., et al. Usefulness of a third Holter lead for detection of myocardial ischemia. Am J Cardiol. 74:1994;1216-1219.
11. Seeberger M.D., Moerlen J., Skarvan K., et al. The inverse Nehb J lead increases the sensitivity of Holter electrocardiographic monitoring for detecting myocardial ischemia. Am J Cardiol. 80:1997;1-5.
12. DiMarco J.P., Philbrick J.T. Use of ambulatory electrocardiographic (Holter) monitoring. Ann Intern Med. 113:1990;53-68.
13. Pratt C.M., Theroux P., Slymen D., et al. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction consecutive ambulatory electrocardiographic recordings of 88 patients . Am J Cardiol. 59:1987;278-283.
14. Mulrow J.P., Healy M.J., McKenna W.J. Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment. Am J Cardiol. 58:1986;615-618.
15. Pratt C.M., Delclos G., Wierman A.M., et al. The changing baseline of complex ventricular arrhythmias a new consideration in assessing long-term antiarrhythmic drug therapy . N Engl J Med. 313:1985;1444-1449.
16. Raeder E.A., Hohnloser S.H., Graboys T.B., et al. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia. J Am Coll Cardiol. 12:1988;656-661.
17. Toivonen L. Spontaneous variability in the frequency of ventricular premature complexes over prolonged intervals and implications for antiarrhythmic treatment. Am J Cardiol. 60:1987;608-612.
18. Michelson E.L., Morganroth J. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation. 61:1980;690-695.
19. Pratt C.M., Slymen D.J., Wierman A.M., et al. Analysis of the spontaneous variability of ventricular arrhythmias consecutive ambulatory electrocardiographic recordings of ventricular tachycardia . Am J Cardiol. 56:1985;67-72.
20. Morganroth J., Michelson E.L., Horowitz L.N., et al. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation. 58:1978;408-414.
21. Anastasiou-Nana M.I., Menlove R.L., Nanas J.N., et al. Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation. 78:1988;286-295.
22. Schmidt G., Ulm K., Barthel P., et al. Spontaneous variability of simple and complex ventricular premature contractions during long time intervals in patients with severe organic heart disease. Circulation. 78:1988;296-301.
23. Bass E.B., Curtiss E.I., Arena V.C., et al. The duration of Holter monitoring in patients with syncope is 24 hours enough? Arch Intern Med. 150:1990;1073-1078.
24. Deanfield J.E., Maseri A., Selwyn A.P., et al. Myocardial ischaemia during daily life in patients with stable angina its relation to symptoms and heart rate changes . Lancet. 2:1983;753-758.
25. Tzivoni D., Gavish A., Benhorin J., et al. Day-to-day variability of myocardial ischemic episodes in coronary artery disease. Am J Cardiol. 60:1987;1003-1005.
26. Nabel E.G., Barry J., Rocco M.B., et al. Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. Circulation. 78:1988;60-67.
27. Nademanee K., Christenson P.D., Intarachot V., et al. Variability of indexes for myocardial ischemia a comparison of exercise treadmill test, ambulatory electrocardiographic monitoring and symptoms of myocardial ischemia . J Am Coll Cardiol. 13:1989;574-579.
28. Celermajer D.S., Spiegelhalter D.J., Deanfield M., et al. Variability of episodic ST segment depression in chronic stable angina implications for individual and group trials of therapeutic efficacy . J Am Coll Cardiol. 23:1994;66-73.
29. Andrews T.C., Fenton T., Toyosaki N., et al. Subsets of ambulatory myocardial ischemia based on heart rate activity circadian distribution and response to anti-ischemic medication: the Angina and Silent Ischemia Study Group (ASIS) . Circulation. 88:1993;92-100.
30. Stone P.H., McMahon R.P., Andrews T.C., et al. Heart rate during daily activities and reproducibility of ischemia using ambulatory ECG monitoring the Psychophysiological Investigations of Myocardial Ischemia (PIMI) study . (abstr) Circulation. 94:(Suppl I):1996;I-78.
31. Roelke M., Ruskin J.M. Arrhythmias detected with implantable cardioverter-defibrillators. Moss A.J. Noninvasive electrocardiography: clinical aspects of Holter monitoring. 1996;93-105 WB Saunders Co Ltd, Philadelphia, PA.
32. Coumel P., Thomas O., Leenhardt A. Holter functions of the implantable cardioverter defibrillator what is still missing? Pacing Clin Electrophysiol. 18:1995;560-568.
33. Pratt C.M., Eaton T., Francis M., et al. Ambulatory electrocardiographic recordings the Holter monitor . Curr Probl Cardiol. 13:1988;517-586.
34. Stone P.H., Chaitman B.R., McMahon R.P., et al. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Study relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease . Circulation. 94:1996;1537-1544.
35. Cohn P.F., Kannel W.B. Recognition, pathogenesis, and management options in silent coronary artery disease. Circulation. 75:1987;II1.
36. Algra A., Tijssen J.G., Roelandt J.R., et al. QT interval variables from 24 hour electrocardiography and the 2 year risk of sudden death. Br Heart J. 70:1993;43-48.
37. Zareba W. Ventricular repolarization measures QT interval, Rtm interval or T wave loop morphology? Ann Noninvas Electrocardiol. 2:1997;101-103.
38. Schneider A.E., Plewan A., Schmitt C., et al. The signal-averaged ECG obtained by a new digital Holter recording system. Ann Noninvas Electrocardiol. 1:1996;379-385.
39. Bigger J.T. Spectral analysis of R-R variability to evaluate autonomic physiology and pharmacology and to predict cardiovascular outcomes in humans. Zipes D.P. Cardiac electrophysiology: from cell to bedside. 2nd ed. 1995;1151-1170 WB Saunders Co, Philadelphia, PA.
40. Malik M., Camm A.J. Components of heart rate variability what they really mean and what we really measure . Am J Cardiol. 72:1993;821-822.
41. Stein K.S., Bosner M.D., Kleiger R.E., et al. Heart rate variability a measure of cardiac autonomic tone . Am Heart J. 127:1994;1376-1381.
42. Pagani M., Lombardi F., Malliani A. Heart rate variability disagreement on the markers of sympathetic and parasympathetic activities . J Am Coll Cardiol. 22:1993;951-953.
43. Akselrod S., Gordon D., Ubel F.A., et al. Power spectrum analysis of heart rate fluctuation a quantitative probe of beat-to-beat cardiovascular control . Science. 213:1981;220-222.
44. Pomeranz B., Macaulay R.J., Caudill M.A., et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 248:1985;H151-H153.
45. Heart rate variability standards of measurement, physiological interpretation, and clinical use . Circulation. 93:1996;1043-1065.
46. Rinoli T., Porges S.W. Inferential and descriptive influences on measures of respiratory sinus arrhythmia sampling rate, R-wave trigger accuracy, and variance estimates . Psychophysiology. 34:1997;613-621.
47. Friesen G.M., Jannett T.C., Jadallah M.A., et al. A comparison of the noise sensitivity of nine QRS detection algorithms. IEEE Trans Biomed Eng. 37:1990;85-98.
48. Bartoli F., Baselli G., Cerutti S. Application of identification and linear filtering algorithms to the R-R interval measurements. Computers in cardiology. 1982;485-488 IEEE Computer Society, Silver Spring, Md.
49. Merri M., Farden D.C., Mottley J.G., et al. Sampling frequency of the electrocardiogram for spectral analysis of the heart rate variability. IEEE Trans Biomed Eng. 37:1990;99-106.
50. Cheung M.N. Detection of and recovery from errors in cardiac interbeat intervals. Psychophysiology. 18:1981;341-346.
51. Berntson G.G., Quigley K.S., Jang J.F., et al. An approach to artifact identification application to heart period data . Psychophysiology. 27:1990;586-598.
52. Linden W., Estrin R. Computerized cardiovascular monitoring method and data . Psychophysiology. 25:1988;227-234.
53. Saul J.P., Arai Y., Berger R.D., et al. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol. 61:1988;1292-1299.
54. Kleiger R.E., Bigger J.T., Bosner M.S., et al. Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol. 68:1991;626-630.
55. Umetani K., Singer D., McCraty R., et al. Twenty-four hour time domain heart rate variability and heart rate relations to age and gender over 9 decades . J Am Coll Cardiol. 31:1998;593-601.
56. Bigger J.T., Fleiss J.L., Steinman R.C., et al. Correlations among time and frequency domain measures of heart period variability 2 weeks after acute myocardial infarction. Am J Cardiol. 69:1992;891-898.
57. Stein P.K., Rottman J.N., Kleiger R.E. Time domain measure of heart rate variability as surrogates for frequency domain measures in stable congestive heart failure patients and normals. (abstr) Circulation. 90:(Suppl I):1994;I-331.
58. Diamond T.H., Smith R., Myburgh D.P. Holter monitoring a necessity for the evaluation of palpitations . S Afr Med J. 63:1983;5-7.
59. Kapoor W.N., Cha R., Peterson J.R., et al. Prolonged electrocardiographic monitoring in patients with syncope importance of frequent or repetitive ventricular ectopy . Am J Med. 82:1987;20-28.
60. Kennedy H.L., Underhill S.J. Frequent or complex ventricular ectopy in apparently healthy subjects a clinical study of 25 cases . Am J Cardiol. 38:1976;141-148.
61. Raftery E.B., Cashman P.M. Long-term recording of the electrocardiogram in a normal population. Postgrad Med J. 52:(Suppl 7):1976;32-38.
62. Glasser S.P., Clark P.I., Applebaum H.J. Occurrence of frequent complex arrhythmias detected by ambulatory monitoring findings in an apparently healthy asymptomatic elderly population . Chest. 75:1979;565-568.
63. Kostis J.B., McCrone K., Moreyra A.E., et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation. 63:1981;1351-1356.
64. Linzer M., Yang E.H., Estes N.A., et al. Diagnosing syncope, I value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians . Ann Intern Med. 126:1997;989-996.
65. Linzer M., Yang E.H., Estes N.A., et al. Diagnosing syncope, II unexplained syncope: Clinical Efficacy Assessment Project of the American College of Physicians . Ann Intern Med. 127:1997;76-86.
66. Gibson T.C., Heitzman M.R. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol. 53:1984;1013-1017.
67. Kala R., Viitasalo M.T., Toivonen L., et al. Ambulatory ECG recording in patients referred because of syncope or dizziness. Acta Med Scand Suppl. 668:1982;13-19.
68. Zeldis S.M., Levine B.J., Michelson E.L., et al. Cardiovascular complaints correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring . Chest. 78:1980;456-461.
69. Clark P.I., Glasser S.P., Spoto E. Jr. Arrhythmias detected by ambulatory monitoring lack of correlation with symptoms of dizziness and syncope . Chest. 77:1980;722-725.
70. Bhandari A.K., Anderson J.L., Gilbert E.M., et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation a transtelephonic monitoring study: the Flecainide Supraventricular Tachycardia Study Group . Am Heart J. 124:1992;381-386.
71. Kinlay S., Leitch J.W., Neil A., et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations a controlled clinical trial . Ann Intern Med. 124:1996;16-20.
72. Schmidt S.B., Jain A.C. Diagnostic utility of memory equipped transtelephonic monitors. Am J Med Sci. 296:1988;299-302.
73. Linzer M., Pritchett E.L., Pontinen M., et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 66:1990;214-219.
74. Shimada M., Akaishi M., Asakura K., et al. Usefulness of the newly developed transtelephonic electrocardiogram and computer-supported response system. J Cardiol. 27:1996;211-217.
75. Kus T., Nadeau R., Costi P., et al. Comparison of the diagnostic yield of Holter versus transtelephonic monitoring. Can J Cardiol. 11:1995;891-894.
76. Murdock C.J., Klein G.J., Yee R., et al. Feasibility of long-term electrocardiographic monitoring with an implanted device for syncope diagnosis. Pacing Clin Electrophysiol. 13:1990;1374-1378.
77. Leitch J., Klein G., Yee R., et al. Feasibility of an implantable arrhythmia monitor. Pacing Clin Electrophysiol. 15:1992;2232-2235.
78. Boudoulas H., Schaal S.F., Lewis R.P., et al. Superiority of 24-hour outpatient monitoring over multi-stage exercise testing for the evaluation of syncope. J Electrocardiol. 12:1979;103-108.
79. Jonas S., Klein I., Dimant J. Importance of Holter monitoring in patients with periodic cerebral symptoms. Ann Neurol. 1:1977;470-474.
80. Page R.L., Wilkinson W.E., Clair W.K., et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 89:1994;224-227.
81. Clair W.K., Wilkinson W.E., McCarthy E.A., et al. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation. 87:1993;1114-1122.
82. Kessler D.K., Kessler K.M. Is ambulatory electrocardiography useful in the evaluation of patients with recent stroke? Chest. 107:1995;916-918.
83. Assayag P., Chailley O., Lehner J.P., et al. Contribution of sequential voluntary ambulatory monitoring in the diagnosis of arrhythmia a multicenter study of 1287 symptomatic patients . Arch Mal Coeur Vaiss. 85:1992;281-286.
84. Bigger J.T. Jr, Fleiss J.L., Kleiger R., et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 69:1984;250-258.
85. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
86. McClements B.M., Adgey A.A. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 21:1993;1419-1427.
87. Hohnloser S.H., Franck P., Klingenheben T., et al. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era a prospective trial . Circulation. 90:1994;1747-1756.
88. Cairns J.A., Connolly S.J., Roberts R., et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT, Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 349:1997;675-682.
89. Farrell T.G., Bashir Y., Cripps T., et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 18:1991;687-697.
90. El-Sherif N., Denes P., Katz R., et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period: the Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. J Am Coll Cardiol. 25:1995;908-914.
91. Gomes J.A., Winters S.L., Martinson M., et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats a prospective study . J Am Coll Cardiol. 13:1989;377-384.
92. Davis B.R., Friedman L.M., Lichstein E. The prognostic value of the duration of the ambulatory electrocardiogram after myocardial infarction. Med Decis Making. 8:1988;9-18.
93. Davis B.R., Friedman L.M., Lichstein E. Are 24 hours of ambulatory ECG monitoring necessary for a patient after infarction? Am Heart J. 115:1988;83-91.
94. Mukharji J., Rude R.E., Poole W.K., et al. Risk factors for sudden death after acute myocardial infarction 2-year follow-up . Am J Cardiol. 54:1984;31-36.
95. Kleiger R.E., Miller J.P., Bigger J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:1987;256-262.
96. Kostis J.B., Byington R., Friedman L.M., et al. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol. 10:1987;231-242.
97. Kuchar D.L., Thorburn C.W., Sammel N.L. Prediction of serious arrhythmic events after myocardial infarction signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography . J Am Coll Cardiol. 9:1987;531-538.
98. de Cock C.C., Visser F.C., van Eenige M.J., et al. Independent prognostic value of supraventricular arrhythmias on 24-h ambulatory monitoring following myocardial infarction. Eur Heart J. 12:1991;1070-1075.
99. Wilson A.C., Kostis J.B. The prognostic significance of very low frequency ventricular ectopic activity in survivors of acute myocardial infarction BHAT Study Group . Chest. 102:1992;732-736.
100. Pedretti R., Etro M.D., Laporta A., et al. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol. 71:1993;1131-1141.
101. Denes P., Gillis A.M., Pawitan Y., et al. Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol. 68:1991;887-896.
102. Dittrich H., Gilpin E., Nicod P., et al. Acute myocardial infarction in women influence of gender on mortality and prognostic variables . Am J Cardiol. 62:1988;1-7.
103. Moss A.J., Carleen E. Gender differences in the mortality risk associated with ventricular arrhythmias after myocardial infarction. Eaker E., Packard B., Wenger N.K., et al. Coronary heart disease in women. 1986;204-207 Haymarket Doyma, Inc, New York.
104. Bigger J.T., Fleiss J.L., Steinman R.C., et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 85:1992;164-171.
105. Zhang Y.Z., Wang S.W., Hu D.Y., et al. Prediction of life-threatening arrhythmia in patients after myocardial infarction by late potentials, ejection fraction and Holter monitoring. Jpn Heart J. 33:1992;15-23.
106. La Rovere M.T., Bigger J.T. Jr, Marcus F.I., et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 351:1998;478-484.
107. Odemuyiwa O., Malik M., Farrell T., et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol. 68:1991;434-439.
108. Bigger J.T., Fleiss J.L., Rolnitzky L.M., et al. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol. 21:1993;729-736.
109. Faber T.S., Staunton A., Hnatkova K., et al. Stepwise strategy of using short- and long-term heart rate variability for risk stratification after myocardial infarction. Pacing Clin Electrophysiol. 19:1996;1845-1851.
110. Fei L., Malik M. Short-term and long-term assessment of heart rate variability for postinfarction risk stratification. Malik M., Camm A.J. Heart rate variability. 1995;341-346 Futura Publishing Co, Inc, Armonk, NY.
111. Malik M., Camm A.J. Significance of long term components of heart rate variability for the further prognosis after acute myocardial infarction. Cardiovasc Res. 24:1990;793-803.
112. Bigger J.T., Fleiss J.L., Rolnitzky L.M., et al. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 88:1993;927-934.
113. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 335:1996;1933-1940.
114. Sim I., McDonald K.M., Lavori P.W., et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation. 96:1997;2823-2829.
115. Huang S.K., Messer J.V., Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy observations in 35 patients . Am J Cardiol. 51:1983;507-512.
116. Kron J., Hart M., Schual-Berke S., et al. Idiopathic dilated cardiomyopathy role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death . Chest. 93:1988;85-90.
117. Holmes J., Kubo S.H., Cody R.J., et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy prediction of mortality by ambulatory electrocardiography . Am J Cardiol. 55:1985;146-151.
118. Unverferth D.V., Magorien R.D., Moeschberger M.L., et al. Factors influencing the 1-year mortality of dilated cardiomyopathy. Am J Cardiol. 54:1984;147-152.
119. Pelliccia F., Gallo P., Cianfrocca C., et al. Relation of complex ventricular arrhythmias to presenting features and prognosis in dilated cardiomyopathy. Int J Cardiol. 29:1990;47-54.
120. Ikegawa T., Chino M., Hasegawa H., et al. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with dilative cardiomyopathy a prospective study . Clin Cardiol. 10:1987;78-82.
121. Szabo B.M., van Veldhuisen D.J., Crijns H.J., et al. Value of ambulatory electrocardiographic monitoring to identify risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J. 15:1994;928-933.
122. Doval H.C., Nul D.R., Grancelli H.O., et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death: GESICA-GEMA Investigators. Circulation. 94:1996;3198-3203.
123. Kienzle M.G., Ferguson D.W., Birkett C.L., et al. Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol. 69:1992;761-767.
124. Casolo G., Balli E., Taddei T., et al. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol. 64:1989;1162-1167.
125. Townend J.N., West J.N., Davies M.K., et al. Effect of quinapril on blood pressure and heart rate in congestive heart failure. Am J Cardiol. 69:1992;1587-1590.
126. Binkley P.F., Haas G.J., Starling R.C., et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 21:1993;655-661.
127. Hoffmann J., Grimm W., Menz V., et al. Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol. 19:1996;1841-1844.
128. Hohnloser S.H., Klingenheben T., van de Loo A., et al. Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation. 89:1994;1068-1073.
129. Fei L., Keeling P.J., Gill J.S., et al. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. Br Heart J. 71:1994;322-328.
130. Ponikowski P., Anker S.D., Chua T.P., et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 79:1997;1645-1650.
131. Fauchier L., Babuty D., Cosnay P., et al. Heart rate variability in idiopathic dilated cardiomyopathy characteristics and prognostic value . J Am Coll Cardiol. 30:1997;1009-1014.
132. Jiang W., Hathaway W.R., McNulty S., et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol. 80:1997;808-811.
133. Maron B.J., Savage D.D., Wolfson J.K., et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy a prospective study . Am J Cardiol. 48:1981;252-257.
134. Fananapazir L., Chang A.C., Epstein S.E., et al. Prognostic determinants in hypertrophic cardiomyopathy. Circulation. 86:1992;730-740.
135. McKenna W.J., Oakley C.M., Krikler D.M., et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 53:1985;412-416.
136. Counihan P.J., Fei L., Bashir Y., et al. Assessment of heart rate variability in hypertrophic cardiomyopathy association with clinical and prognostic features . Circulation. 88:1993;1682-1690.
137. Marangoni S., Scalvini S., Mai R., et al. Heart rate variability assessment in patients with mitral valve prolapse syndrome. Am J Noninvas Cardiol. 7:1993;210-214.
138. Stein K.M., Borer J.S., Hochreiter C., et al. Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation. 88:1993;127-135.
139. Hoffmann A., Burckhardt D. Patients at risk for cardiac death late after aortic valve replacement. Am Heart J. 120:1990;1142-1147.
140. Ewing D.J., Campbell I.W., Clarke B.F. The natural history of diabetic autonomic neuropathy. Q J Med. 49:1980;95-108.
141. Malpas S.C., Maling T.J. Heart-rate variability and cardiac autonomic function in diabetes. Diabetes. 39:1990;1177-1181.
142. Ewing D.J., Neilson J.M., Shapiro C.M., et al. Twenty four hour heart rate variability effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients . Br Heart J. 65:1991;239-244.
143. Pagani M., Malfatto G., Pierini S., et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst. 23:1988;143-153.
144. Bellavere F., Balzani I., De Masi G., et al. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes. 41:1992;633-640.
145. Blumberg A., Hausermann M., Strub B., et al. Cardiac arrhythmias in patients on maintenance hemodialysis. Nephron. 33:1983;91-95.
146. Abe S., Yoshizawa M., Nakanishi N., et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 131:1996;1137-1144.
147. D'Elia J.A., Weinrauch L.A., Gleason R.E., et al. Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med. 148:1988;2381-2385.
148. Lown B., Wolfe M. Approaches to sudden death from coronary artery disease. Circulation. 44:1971;130-142.
149. Kannel W.B., Gordon T., Offutt D. Left ventricular hypertrophy by electrocardiogram prevalence, incidence, and mortality in the Framingham study . Ann Intern Med. 71:1969;89-105.
150. Messerli F.H., Ventura H.O., Elizardi D.J., et al. Hypertension and sudden death increased ventricular ectopic activity in left ventricular hypertrophy . Am J Med. 77:1984;18-22.
151. McLenachan J.M., Henderson E., Morris K.I., et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 317:1987;787-792.
152. Siegel D., Cheitlin M.D., Black D.M., et al. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol. 65:1990;742-747.
153. Ferrara N., Furgi G., Longobardi G., et al. Relation between age, left ventricular mass and ventricular arrhythmias in patients with hypertension. J Hum Hypertens. 9:1995;581-587.
154. Kannel W.B., Dannenberg A.L., Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol. 60:1987;85I-93I.
155. Levy D., Anderson K.M., Savage D.D., et al. Risk of ventricular arrhythmias in left ventricular hypertrophy the Framingham Heart Study . Am J Cardiol. 60:1987;560-565.
156. Bikkina M., Larson M.G., Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 22:1993;1111-1116.
157. O'Kelly B., Browner W.S., Massie B., et al. Ventricular arrhythmias in patients undergoing noncardiac surgery the Study of Perioperative Ischemia Research Group . JAMA. 268:1992;217-221.
158. Huikuri H.V., Yli-Mayry S., Korhonen U.R., et al. Prevalence and prognostic significance of complex ventricular arrhythmias after coronary arterial bypass graft surgery. Int J Cardiol. 27:1990;333-339.
159. Juul-Moller S., Hedblad B., Janzon L., et al. Increased occurrence of arrhythmias in men with ischaemic type ST-segment depression during long-term ECG recording prognostic impact on ischaemic heart disease: results from the prospective population study 'Men born in 1914,' Malmo, Sweden . J Intern Med. 230:1991;143-149.
160. Gheno G., Mazzei G. Prognostic value of Holter monitoring in asymptomatic elderly subjects with sinus rhythm. J Electrocardiol. 29:1996;39-44.
161. Martin A., Benbow L.J., Butrous G.S., et al. Five-year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring. Eur Heart J. 5:1984;592-596.
162. Kennedy H.L., Whitlock J.A., Sprague M.K., et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 312:1985;193-197.
163. Bikkina M., Larson M.G., Levy D. Prognostic implications of asymptomatic ventricular arrhythmias the Framingham Heart Study . Ann Intern Med. 117:1992;990-996.
164. Shih H.T., Webb C.R., Conway W.A., et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest. 94:1988;44-48.
165. Fabian T.C., Cicala R.S., Croce M.A., et al. A prospective evaluation of myocardial contusion correlation of significant arrhythmias and cardiac output with CPK-MB measurements . J Trauma. 31:1991;653-660.
166. Zohar Y., Talmi Y.P., Frenkel H., et al. Cardiac function in obstructive sleep apnea patients following uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg. 107:1992;390-394.
167. Flemons W.W., Remmers J.E., Gillis A.M. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis. 148:1993;618-621.
168. Snisarenko A.A. Cardiac rhythm in cats during physiological sleep in experimental myocardial infarction and beta-adrenergic receptor blockade. Cor Vasa. 28:1986;306-314.
169. Molgaard H., Mickley H., Pless P., et al. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol. 71:1993;1357-1359.
170. Filipecki A., Trusz-Gluza M., Szydlo K., et al. Effect of propranolol and propafenone on heart rate variability in patients with ventricular arrhythmias. (abstr) Pacing Clin Electrophysiol. 16:1993;1157.
171. Bekheit S., Tangella M., el-Sakr A., et al. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J. 119:1990;79-85.
172. Zuanetti G., Latini R., Neilson J.M., et al. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs: Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol. 17:1991;604-612.
173. Hohnloser S.H., Klingenheben T., Zabel M., et al. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias . Am J Cardiol. 72:1993;67A-71A.
174. Olson H.G., Lyons K.P., Troop P., et al. The high-risk acute myocardial infarction patient at 1-year follow-up identification at hospital discharge by ambulatory electrocardiography and radionuclide ventriculography . Am Heart J. 107:1984;358-366.
175. Richards D.A., Byth K., Ross D.L., et al. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 83:1991;756-763.
176. Olona M., Candell-Riera J., Permanyer-Miralda G., et al. Strategies for prognostic assessment of uncomplicated first myocardial infarction 5-year follow-up study . J Am Coll Cardiol. 25:1995;815-822.
177. Anderson J.L., Gilbert E.M., Alpert B.L., et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy a multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring: Flecainide Supraventricular Tachycardia Study Group . Circulation. 80:1989;1557-1570.
178. Winkle R.A., Peters F., Hall R. Characterization of ventricular tachyarrhythmias on ambulatory ECG recordings in post-myocardial infarction patients arrhythmia detection and duration of recording, relationship between arrhythmia frequency and complexity, and day-to-day reproducibility . Am Heart J. 102:1981;162-169.
179. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction the CAPS . Am J Cardiol. 61:1988;501-509.
180. Reiter M.J., Karagounis L.A., Mann D.E., et al. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial: ESVEM Investigators. Am J Cardiol. 79:1997;315-322.
181. Anastasiou-Nana M.I., Gilbert E.M., Miller R.H., et al. Usefulness of d,l sotalol for suppression of chronic ventricular arrhythmias. Am J Cardiol. 67:1991;511-516.
182. Kennedy H.L. Noncardiac adverse events and organ toxicity of moricizine during short- and long-term studies. Am J Cardiol. 65:1990;47D-50D.
183. Schmidt G., Ulm K., Barthel P. Variability of ventricular premature contractions. (letter) Circulation. 79:1989;1149-1151.
184. Anderson J.L., Anastasiou-Nana M.I., Menlove R.L., et al. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy. Circulation. 82:1990;830-840.
185. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction . N Engl J Med. 321:1989;406-412.
186. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo the Cardiac Arrhythmia Suppression Trial . N Engl J Med. 324:1991;781-788.
187. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction the Cardiac Arrhythmia Suppression Trial II Investigators . N Engl J Med. 327:1992;227-233.
188. Epstein A.E., Hallstrom A.P., Rogers W.J., et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST) . JAMA. 270:1993;2451-2455.
189. Wyse D.G., Hallstrom A., McBride R., et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST) mortality in patients surviving open label titration but not randomized to double-blind therapy . J Am Coll Cardiol. 18:1991;20-28.
190. Hallstrom A.P., Greene H.L., Huther M.L. The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators. Stat Med. 10:1991;1621-1631.
191. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction an overview of results from randomized controlled trials . JAMA. 270:1993;1589-1595.
192. Waldo A.L., Camm A.J., deRuyter H., et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction the SWORD Investigators: Survival With Oral d-Sotalol . Lancet. 348:1996;7-12.
193. Burkart F., Pfisterer M., Kiowski W., et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias Basel Antiarrhythmic Study of Infarct Survival (BASIS) . J Am Coll Cardiol. 16:1990;1711-1718.
194. Ceremuzynski L., Kleczar E., Krzeminska-Pakula M., et al. Effect of amiodarone on mortality after myocardial infarction a double-blind, placebo-controlled, pilot study . J Am Coll Cardiol. 20:1992;1056-1062.
195. Doval H.C., Nul D.R., Grancelli H.O., et al. Randomised trial of low-dose amiodarone in severe congestive heart failure Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) . Lancet. 344:1994;493-498.
196. Randomized drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol. 72:1993;280-287.
197. Julian D.G., Camm A.J., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT, European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 349:1997;667-674.
198. Singh S.N., Fletcher R.D., Fisher S.G., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure . N Engl J Med. 333:1995;77-82.
199. Graboys T.B., Lown B., Podrid P.J., et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol. 50:1982;437-443.
200. Lampert S., Lown B., Graboys T.B., et al. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Am J Cardiol. 61:1988;791-797.
201. Mitchell L.B., Duff H.J., Manyari D.E., et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med. 317:1987;1681-1687.
202. Mason J.W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias: Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. N Engl J Med. 329:1993;445-451.
203. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
204. Swerdlow C.D., Peterson J. Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias. Am J Cardiol. 56:1985;577-580.
205. Pritchett E.L., Lee K.L. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias. J Clin Epidemiol. 41:1988;851-858.
206. Jung F., DiMarco J.P. Antiarrhythmic drug therapy in the treatment of atrial fibrillation. Cardiol Clin. 14:1996;507-520.
207. Kennedy H.L. Late proarrhythmia and understanding the time of occurrence of proarrhythmia. Am J Cardiol. 66:1990;1139-1143.
208. Morganroth J., Pratt C.M. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine). Am J Cardiol. 63:1989;172-176.
209. Wyse D.G., Morganroth J., Ledingham R., et al. New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study: the CAST and CAPS Investigators. J Am Coll Cardiol. 23:1994;1130-1140.
210. Furman S., Hayes D.L., Homes D.R. Telemetry. A practice of cardiac pacing. 3rd ed. 1993;633 Futura Publishing, Mt Kisco, NY.
211. Newman D., Dorian P., Downar E., et al. Use of telemetry function in the assessment of implanted antitachycardia device efficacy. Am J Cardiol. 70:1992;616-621.
212. Lascault G., Frank R., Himbert C., et al. Diagnosis of ventricular tachycardia using a pacemaker Holter function. Pacing Clin Electrophysiol. 17:1994;1316-1319.
213. Levine P.A., Sanders R., Rankowitz H.T. Pacemaker diagnostics measured data, event marker, electrogram, and event counter telemetry . Ellenbogen K.A., Kay G.N. Clinical cardiac pacing. 1995;639-655 WB Saunders Co, Philadelphia, PA.
214. Ben-Zur U., Platt S.B., Gross J.N., et al. Direct and telemetered lead impedance. Pacing Clin Electrophysiol. 17:1994;2004-2007.
215. Schuchert A., Cappato R., Kuck K.H., et al. Reliability and variability of impedance measured by real-time telemetry. Pacing Clin Electrophysiol. 19:1996;265-271.
216. Dreifus L.S., Fisch C., Griffin J.C., et al. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation) . J Am Coll Cardiol. 18:1991;1-13.
217. Janosik D.L., Redd R.M., Buckingham T.A., et al. Utility of ambulatory electrocardiography in detecting pacemaker dysfunction in the early postimplantation period. Am J Cardiol. 60:1987;1030-1035.
218. Begemann M.J., Boute W. Heart rate monitoring in implanted pacemakers. Pacing Clin Electrophysiol. 11:1988;1687-1692.
219. Nowak B., Middeldorf T., Housworth C.M., et al. Holter recordings with continuous marker annotations a new tool in pacemaker diagnostics . Pacing Clin Electrophysiol. 19:1996;1791-1795.
220. Reiter M.J., Fain E.S., Senelly K.M., et al. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators: CADENCE Investigators. Pacing Clin Electrophysiol. 17:1994;1487-1498.
221. Birgersdotter-Green U., Rosenqvist M., Lindemans F.W., et al. Holter documented sudden death in a patient with an implanted defibrillator. Pacing Clin Electrophysiol. 15:1992;1008-1014.
222. Callans D.J., Hook B.G., Kleiman R.B., et al. Unique sensing errors in third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol. 22:1993;1135-1140.
223. Krahn A.D., Klein G.J., Yee R., et al. Use of an extended monitoring strategy in patients with problematic syncope. Circulation. 99:1999;406-410.
224. Mugica J., Thornander H. An experimental implantable "Holter" Feruglio G. Cardiac pacing electrophysiology and pacemaker technology . 1991;1311-1314 Piccin Medical Books, Padova, Italy.
225. Crawford M.H., Mendoza C.A., O'Rourke R.A., et al. Limitations of continuous ambulatory electrocardiogram monitoring for detecting coronary artery disease. Ann Intern Med. 89:1978;1-5.
226. Schang S.J., Pepine C.J. Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol. 39:1977;396-402.
227. Deedwania P.C., Carbajal E.V. Silent myocardial ischemia a clinical perspective . Arch Intern Med. 151:1991;2373-2382.
228. Deedwania P.C., Carbajal E.V. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol. 65:1990;1090-1096.
229. Cohn P.F. Silent myocardial ischemia dimensions of the problem in patients with and without angina . Am J Med. 80:1986;3-8.
230. Gottlieb S.O., Weisfeldt M.L., Ouyang P., et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 314:1986;1214-1219.
231. Rocco M.B., Nabel E.G., Campbell S., et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation. 78:1988;877-884.
232. Deedwania P.C., Carbajal E.V. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 81:1990;748-756.
233. Tzivoni D., Gavish A., Zin D., et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol. 62:1988;661-664.
234. Raby K.E., Goldman L., Cook E.F., et al. Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol. 66:1990;1309-1313.
235. de Marchena E., Asch J., Martinez J., et al. Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris. Am J Cardiol. 73:1994;390-392.
236. Yeung A.C., Barry J., Orav J., et al. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease. Circulation. 83:1991;1598-1604.
237. Deedwania P.C., Carbajal E.V. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am J Cardiol. 68:1991;1279-1286.
238. Madjlessi-Simon T., Mary-Krause M., et al. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol. 27:1996;1586-1591.
239. Currie P., Ashby D., Saltissi S. Prognostic significance of transient myocardial ischemia on ambulatory monitoring after acute myocardial infarction. Am J Cardiol. 71:1993;773-777.
240. Gottlieb S.O., Gottlieb S.H., Achuff S.C., et al. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA. 259:1988;1030-1035.
241. Deedwania P.C. Asymptomatic ischemia during predischarge Holter monitoring predicts poor prognosis in the postinfarction period. Am J Cardiol. 71:1993;859-861.
242. Gill J.B., Cairns J.A., Roberts R.S., et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med. 334:1996;65-70.
243. Mulcahy D., Keegan J., Sparrow J., et al. Ischemia in the ambulatory setting the total ischemic burden: relation to exercise testing and investigative and therapeutic implications . J Am Coll Cardiol. 14:1989;1166-1172.
244. Deedwania P.C., Carbajal E.V. Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris. Am J Cardiol. 66:1990;1151-1156.
245. Krantz D.S., Helmers K.F., Bairey C.N., et al. Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease. Psychosom Med. 53:1991;1-12.
246. Gabbay F.H., Krantz D.S., Kop W.J., et al. Triggers of myocardial ischemia during daily life in patients with coronary artery disease physical and mental activities, anger and smoking . J Am Coll Cardiol. 27:1996;585-592.
247. Sharaf B.L., Williams D.O., Miele N.J., et al. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory . J Am Coll Cardiol. 29:1997;78-84.
248. Jiang W., Babyak M., Krantz D.S., et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA. 275:1996;1651-1656.
249. Pepine C.J., Sharaf B., Andrews T.C., et al. Relation between clinical, angiographic, and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot Study. J Am Coll Cardiol. 29:1997;1483-1489.
250. Raby K.E., Goldman L., Creager M.A., et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med. 321:1989;1296-1300.
251. Raby K.E., Barry J., Creager M.A., et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA. 268:1992;222-227.
252. Mangano D.T., Browner W.S., Hollenberg M., et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery the Study of Perioperative Ischemia Research Group . N Engl J Med. 323:1990;1781-1788.
253. Fleisher L.A., Rosenbaum S.H., Nelson A.H., et al. The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. Am Heart J. 122:1991;980-986.
254. Kirwin J.D., Ascer E., Gennaro M., et al. Silent myocardial ischemia is not predictive of myocardial infarction in peripheral vascular surgery patients. Ann Vasc Surg. 7:1993;27-32.
255. McPhail N.V., Ruddy T.D., Barber G.G., et al. Cardiac risk stratification using dipyridamole myocardial perfusion imaging and ambulatory ECG monitoring prior to vascular surgery. Eur J Vasc Surg. 7:1993;151-155.
256. Pasternack P.F., Grossi E.A., Baumann F.G., et al. The value of silent myocardial ischemia monitoring in the prediction of perioperative myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc Surg. 10:1989;617-625.
257. Fleisher L.A., Rosenbaum S.H., Nelson A.H., et al. Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long-term outcome. Anesthesiology. 83:1995;906-917.
258. Mangano D.T., Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 333:1995;1750-1756.
259. Mangano D.T., Browner W.S., Hollenberg M., et al. Long-term cardiac prognosis following noncardiac surgery the Study of Perioperative Ischemia Research Group . JAMA. 268:1992;233-239.
260. Patel D.J., Mulcahy D., Norrie J., et al. Natural variability of transient myocardial ischaemia during daily life an obstacle when assessing efficacy of anti-ischaemic agents? Heart. 76:1996;477-482.
261. Stone P.H., Gibson R.S., Glasser S.P., et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation. 82:1990;1962-1972.
262. Deedwania P.C., Carbajal E.V., Nelson J.R., et al. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol. 17:1991;963-969.
263. Davies R.F., Habibi H., Klinke W.P., et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring: Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol. 25:1995;619-625.
264. Pepine C.J., Cohn P.F., Deedwania P.C., et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life the Atenolol Silent Ischemia Study (ASIST) . Circulation. 90:1994;762-768.
265. Knatterud G.L., Bourassa M.G., Pepine C.J., et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study . J Am Coll Cardiol. 24:1994;11-20.
266. Chaitman B.R., Stone P.H., Knatterud G.L., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes: the ACIP Investigators. J Am Coll Cardiol. 26:1995;585-593.
267. Bourassa M.G., Pepine C.J., Forman S.A., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia: the ACIP investigators. J Am Coll Cardiol. 26:1995;606-614.
268. Rogers W.J., Bourassa M.G., Andrews T.C., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization: the ACIP Investigators. J Am Coll Cardiol. 26:1995;594-605.
269. Dargie H.J., Ford I., Fox K.M. Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina: the TIBET Study Group. Eur Heart J. 17:1996;104-112.
270. Von Arnim T. Prognostic significance of transient ischemic episodes response to treatment shows improved prognosis: results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up . J Am Coll Cardiol. 28:1996;20-24.
271. Stone P.H., Chaitman B.R., Forman S. Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by 1 year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). Am J Cardiol. 80:1997;1395-1401.
272. Dick M. II, McFadden D., Crowley D., et al. Diagnosis and management of cardiac rhythm disorders by transtelephonic electrocardiography in infants and children. J Pediatr. 94:1979;612-615.
273. Fyfe D.A., Holmes D.R., Neubauer S.A., et al. Transtelephonic monitoring in pediatric patients with clinically suspected arrhythmias. Clin Pediatr. 23:1984;139-143.
274. Porter C.J., Gillette P.C., McNamara D.G. Twenty-four-hour ambulatory ECGs in the detection and management of cardiac arrhythmias in infants and children. Pediatr Cardiol. 1:1980;203-208.
275. Goldstein M.A., Hesslein P., Dunnigan A. Efficacy of transtelephonic electrocardiographic monitoring in pediatric patients. Am J Dis Child. 144:1990;178-182.
276. Karpawich P.P., Cavitt D.L., Sugalski J.S. Ambulatory arrhythmia screening in symptomatic children and young adults comparative effectiveness of Holter and telephone event recordings . Pediatr Cardiol. 14:1993;147-150.
277. Houyel L., Fournier A., Centazzo S., et al. Use of transtelephonic electrocardiographic monitoring in children with suspected arrhythmias. Can J Cardiol. 8:1992;741-744.
278. Driscoll D.J., Jacobsen S.J., Porter C.J., et al. Syncope in children and adolescents. J Am Coll Cardiol. 29:1997;1039-1045.
279. Zimetbaum P., Kim K.Y., Ho K.K., et al. Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol. 79:1997;371-372.
280. Seliem M.A., Benson D.W., Strasburger J.F., et al. Complex ventricular ectopic activity in patients less than 20 years of age with or without syncope, and the role of ventricular extrastimulus testing. Am J Cardiol. 68:1991;745-750.
281. Selbst S.M., Ruddy R.M., Clark B.J., et al. Pediatric chest pain a prospective study . Pediatrics. 82:1988;319-323.
282. Kaden G.G., Shenker I.R., Gootman N. Chest pain in adolescents. J Adolesc Health. 12:1991;251-255.
283. Wolfe R.R., Driscoll D.J., Gersony W.M., et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect results of 24-hour ECG monitoring . Circulation. 87:(Suppl I):1993;I89-I101.
284. Garson A. Jr, Bink-Boelkens M., Hesslein P.S., et al. Atrial flutter in the young a collaborative study of 380 cases . J Am Coll Cardiol. 6:1985;871-878.
285. Cullen S., Celermajer D.S., Franklin R.C., et al. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot a 12-year prospective study . J Am Coll Cardiol. 23:1994;1151-1155.
286. Chandar J.S., Wolff G.S., Garson A. Jr, et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol. 65:1990;655-661.
287. Garson A. Jr. Ventricular arrhythmia after repair of congenital heart disease who needs treatment? Cardiol Young. 1:1991;177-181.
288. Paul T., Marchal C., Garson A. Jr. Ventricular couplets in the young prognosis related to underlying substrate . Am Heart J. 119:1990;577-582.
289. McKenna W.J., Franklin R.C., Nihoyannopoulos P., et al. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 11:1988;147-153.
290. Garson A. Jr, Dick M. II, Fournier A., et al. The long QT syndrome in children an international study of 287 patients . Circulation. 87:1993;1866-1872.
291. Christiansen J.L., Guccione P., Garson A. Jr. Difference in QT interval measurement on ambulatory ECG compared with standard ECG. Pacing Clin Electrophysiol. 19:1996;1296-1303.
292. Dewey R.C., Capeless M.A., Levy A.M. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med. 316:1987;835-839.
293. Zardini M., Yee R., Thakur R.K., et al. Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome current perspectives . Pacing Clin Electrophysiol. 17:1994;966-975.
294. Silka M.J., Kron J., Walance C.G., et al. Assessment and follow-up of pediatric survivors of sudden cardiac death. Circulation. 82:1990;341-349.
295. Survivors of out-of-hospital cardiac arrest with apparently normal heart need for definition and standardized clinical evaluation: Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States . Circulation. 95:1997;265-272.
296. Yanagisawa A., Miyagawa M., Yotsukura M., et al. The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J. 124:1992;1244-1250.
297. Melacini P., Fanin M., Danieli G.A., et al. Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol. 22:1993;1927-1934.
298. Fragola P.V., Luzi M., Calo L., et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol. 74:1994;1070-1072.
299. Larsen R.L., Jakacki R.I., Vetter V.L., et al. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol. 70:1992;73-77.
300. Pfammatter J.P., Paul T., Lehmann C., et al. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol. 26:1995;1002-1007.
301. Garson A. Jr. Dosing the newer antiarrhythmic drugs in children considerations in pediatric pharmacology . Am J Cardiol. 57:1986;1405-1407.
302. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation. 57:1978;867-870.
303. Fenelon G., d'Avila A., Malacky T., et al. Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia. Am J Cardiol. 75:1995;698-702.
304. Packer D.L., Bardy G.H., Worley S.J., et al. Tachycardia-induced cardiomyopathy a reversible form of left ventricular dysfunction . Am J Cardiol. 57:1986;563-570.